Movement Alert｜Ali Health Falls 3.21% in Regular Trading, Post-Earnings Selling Pressure Compounded by Prescription Drug E-Commerce Regulations

Market Focus05-28

On May 28, Ali Health fell 3.21% in regular trading, trading at HK$3.62/share, with trading volume of HK$132 million, extending post-earnings weakness.

The decline reflects continued selling pressure following the company's FY26 results, which showed second-half revenue growth of only 7.6%, significantly below market expectations of 13.8%. Multiple major banks subsequently downgraded targets: UBS maintained its \"sell\" rating with a target price cut to HK$3.6; Goldman Sachs lowered its target to HK$4.2; CLSA cut its adjusted net profit forecast by 23%; and Bank of America reduced its target from HK$6 to HK$5.1 while cutting FY27-28 adjusted net profit estimates by approximately 20%.

Adding further pressure, newly issued prescription drug online retail guidelines — prohibiting AI-based prescription review substitution and restricting promotional activities for prescription drugs — are expected to raise platform compliance costs and weigh on near-term profitability for pharmaceutical e-commerce players. Sector peers also declined, with JD Health down 3.07% and Ping An Good Doctor down 4.34%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1177284293?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-28 10:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1177284293","market":"us","top_or_hot":-1,"title":"Movement Alert｜Ali Health Falls 3.21% in Regular Trading, Post-Earnings Selling Pressure Compounded by Prescription Drug E-Commerce Regulations","media":"Market Focus","content":"<p><p>On May 28, Ali Health fell 3.21% in regular trading, trading at HK$3.62/share, with trading volume of HK$132 million, extending post-earnings weakness.</p><p>The decline reflects continued selling pressure following the company's FY26 results, which showed second-half revenue growth of only 7.6%, significantly below market expectations of 13.8%. Multiple major banks subsequently downgraded targets: UBS maintained its \\\"sell\\\" rating with a target price cut to HK$3.6; Goldman Sachs lowered its target to HK$4.2; CLSA cut its adjusted net profit forecast by 23%; and Bank of America reduced its target from HK$6 to HK$5.1 while cutting FY27-28 adjusted net profit estimates by approximately 20%.</p><p>Adding further pressure, newly issued prescription drug online retail guidelines — prohibiting AI-based prescription review substitution and restricting promotional activities for prescription drugs — are expected to raise platform compliance costs and weigh on near-term profitability for pharmaceutical e-commerce players. Sector peers also declined, with JD Health down 3.07% and Ping An Good Doctor down 4.34%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Ali Health Falls 3.21% in Regular Trading, Post-Earnings Selling Pressure Compounded by Prescription Drug E-Commerce Regulations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Ali Health Falls 3.21% in Regular Trading, Post-Earnings Selling Pressure Compounded by Prescription Drug E-Commerce Regulations\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-05-28 10:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On May 28, Ali Health fell 3.21% in regular trading, trading at HK$3.62/share, with trading volume of HK$132 million, extending post-earnings weakness.</p><p>The decline reflects continued selling pressure following the company's FY26 results, which showed second-half revenue growth of only 7.6%, significantly below market expectations of 13.8%. Multiple major banks subsequently downgraded targets: UBS maintained its \\\"sell\\\" rating with a target price cut to HK$3.6; Goldman Sachs lowered its target to HK$4.2; CLSA cut its adjusted net profit forecast by 23%; and Bank of America reduced its target from HK$6 to HK$5.1 while cutting FY27-28 adjusted net profit estimates by approximately 20%.</p><p>Adding further pressure, newly issued prescription drug online retail guidelines — prohibiting AI-based prescription review substitution and restricting promotional activities for prescription drugs — are expected to raise platform compliance costs and weigh on near-term profitability for pharmaceutical e-commerce players. Sector peers also declined, with JD Health down 3.07% and Ping An Good Doctor down 4.34%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00241","symbol_name":"阿里健康","start_time":0,"source_url":"","article_id":"1177284293","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1177284293","pubTimestamp":1779934356,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On May 28, Ali Health fell 3.21% in regular trading, trading at HK$3.62/share, with trading volume of HK$132 million, extending post-earnings weakness.The decline reflects continued selling pressure...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00241":"阿里健康"},"translate_title":"动向提示|阿里健康常规交易跌3.21%处方药电商监管加剧财报后抛压","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00241":1},"content_text":"On May 28, Ali Health fell 3.21% in regular trading, trading at HK$3.62/share, with trading volume of HK$132 million, extending post-earnings weakness.The decline reflects continued selling pressure following the company's FY26 results, which showed second-half revenue growth of only 7.6%, significantly below market expectations of 13.8%. Multiple major banks subsequently downgraded targets: UBS maintained its \\\"sell\\\" rating with a target price cut to HK$3.6; Goldman Sachs lowered its target to HK$4.2; CLSA cut its adjusted net profit forecast by 23%; and Bank of America reduced its target from HK$6 to HK$5.1 while cutting FY27-28 adjusted net profit estimates by approximately 20%.Adding further pressure, newly issued prescription drug online retail guidelines — prohibiting AI-based prescription review substitution and restricting promotional activities for prescription drugs — are expected to raise platform compliance costs and weigh on near-term profitability for pharmaceutical e-commerce players. Sector peers also declined, with JD Health down 3.07% and Ping An Good Doctor down 4.34%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1177284293","isCrawlerRequest":true}